To make the journey from new molecules to new medications easier, start with a partner who will be beside you at every step.
Today, simplifying your drug development journey takes a smart partner, one with clinical expertise, integrated technologies, and its own early phase hospital-based units already in place on three continents. With a nimble and proven ally saving you time and expense during and between clinical processes, your compounds enter First-in-Human studies faster, which also helps you accelerate your timeline. PAREXEL® has the global SOPs to perform Phase I trials in harmony across multiple locations, and stands committed to the success of your journey.
We also recommend our Quantitative Clinical Development solutions that combine clinical pharmacology modeling and simulation with clinical PK/PD and pharmacometrics for a more strategic approach to clinical development.